Table 3 Clinical characteristics of patients in study of carbon nanoparticles in sentinel lymph nodes biopsy
Parameter | Cases (n) | Proportion (%) |
|---|---|---|
Age | ||
≤50years | 15 | 27.8 |
50–60years | 28 | 51.9 |
60–70years | 8 | 14.8 |
≥70years | 3 | 5.6 |
Menstrual status | ||
Not menopause | 19 | 35.2 |
Menopause ≤5 years | 15 | 27.8 |
Menopause 5–10 years | 9 | 16.7 |
Menopause 10–20 years | 5 | 9.3 |
Menopause ≥20 years | 6 | 11.1 |
Pathological types | ||
Endometrioid adenocarcinoma | 47 | 87.0 |
Other types | 7 | 13.0 |
Degree of cell differentiation | ||
Medium/high differentiation | 44 | 81.5 |
Low differentiation | 10 | 18.5 |
Tumor locations | ||
Cornua uteri | 23 | 42.6 |
Fundus of uterus | 12 | 22.2 |
Corpus uteri | 14 | 25.9 |
Diffused in the uterine cavity | 5 | 9.3 |
Tumor sizes | ||
≤2cm | 35 | 64.8 |
>2cm | 19 | 35.2 |
Depths of invasion | ||
Mucosal layer | 7 | 13.0 |
≤1/2 muscularis | 43 | 79.6 |
>1/2 muscularis | 4 | 7.4 |
Cervical metastasis | ||
Yes | 46 | 85.2 |
No | 8 | 14.8 |
Cervical cyst | ||
Yes | 7 | 13.0 |
No | 47 | 87.0 |
Stiff cervix | ||
Yes | 8 | 14.8 |
No | 46 | 85.2 |
Cervix sizes | ||
Atrophy | 18 | 33.3 |
Normal | 30 | 55.6 |
Hypertrophy | 6 | 11.1 |
Cervix locations | ||
Superficial | 10 | 18.5 |
Normal | 41 | 75.9 |
Deep | 2 | 3.7 |
Out of vagina | 1 | 1.9 |